{"response": {"meta": {"time": 38, "hits": 1, "offset": 0}, "docs": [{"news_desk": null, "document_type": "article", "_id": "4fc4941345c1498b0da6cadb", "headline": {"main": "Breaking the drug barrier"}, "pub_date": "1977-03-20T00:00:00Z", "slideshow_credits": null, "source": "The New York Times", "byline": {"original": "By Richard Spark", "person": [{"lastname": "Spark", "rank": 1, "firstname": "Richard", "organization": "", "role": "reported"}]}, "abstract": "Richard Spark article on 'drug lag,' bureaucratic embargo on new drugs resulting from increasing consumer and Govt interest in benefit-vs-risk formula used to evaluate all drugs; FDA investigations and regulations discussed; illus (L)", "web_url": "http://query.nytimes.com/gst/abstract.html?res=9D01E5D7113BE63BBC4851DFB566838C669EDE", "section_name": null, "lead_paragraph": "Unfortunately, no drug is completely \"safe.\" For example, there is a medication that, when administered in low doses, may cause indigestion and bleeding disorders, and, in higher doses, may result in marked alterations in blood chemistry, stupor, seizures and, on occasion, death. One would hardly expect a medication with such inherent toxicity to be approved for use by laboratory mice, let alone humans.", "snippet": "Unfortunately, no drug is completely \"safe.\" For example, there is a medication that, when administered in low doses, may cause indigestion and bleeding disorders, and, in higher doses, may result in marked alterations in blood  chemistry, stupor,...", "blog": [], "keywords": [{"value": "DRUGS AND DRUG TRADE", "name": "subject"}], "print_page": "228", "type_of_material": "Article", "word_count": 1412, "subsection_name": null, "multimedia": []}]}, "status": "OK", "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}